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We reported previously that the locus for hyperparathy-
roidism–jaw tumor syndrome (MIM 145001), HRPT2,
appeared to be within a 0.7-cM region on chromosome
1q, on the basis of shared haplotype data from two fam-
ilies (Hobbs et al. 1999). The map order of the markers
was originally derived from the chromosome 1 maps from
Ge´ne´thon (Dib et al. 1996; Ge´ne´thon Web site) and the
Whitehead Institute for Genome Research (Whitehead In-
stitute for Genome Research Web site). Recent work by
Carpten et al. (2000) and the human genome sequencing
project (Lander et al. 2001) have shed new light on the
proposed locus. These detailed physical-map data change
the order of two markers (underlined) that are important
in defining the shared haplotype region (in parenthe-
ses), from (D1S466, D1S2701, CHLC.12F10, D1S240,
D1S2848, D1S254), D1S191, D1S444 to (D1S466,
D1S2701, CHLC.12F10, D1S240, D1S254), D1S444,
D1S191, D1S2848 (centromeric to telomeric). This re-
moves D1S2848 from the reported shared haplotype re-
gion. Telomeric to D1S240, a new marker also became
available: 277P67-2A8 (GenBank accession number
AF181675). This marker was not shared between the two
families in question, further reducing the shared haplotype
region to the area defined between D1S466 and D1S240
(∼1.8 cM): (D1S466, D1S2701, CHLC.12F10, D1S240),
277P67-2A8, D1S254, D1S444, D1S191, D1S2848.
For the markers remaining in the shared haplotype re-
gion—D1S466, D1S2701, CHLC.12F10, and D1S240—
the frequencies for the alleles found in the affected hap-
lotype are 0.06, 0.74, 0.18, and 0.50, respectively. This
gives a calculated frequency in the general population of
0.004, or 1/250. This haplotype is much more common
than that calculated for the original proposed shared hap-
lotype region (population frequency of 1/38,000) and in-
dicates that the newly reduced shared haplotype region
is not indicative of an HRPT2 haplotype.
Furthermore, the reduced shared haplotype region
(D1S466 to D1S240) now no longer overlaps with the
nonrecombinant region for our families (277P67-2A8 to
D1S306, or D1S477 in current databases [Human Ge-
nome Working Draft Web site]). We conclude that the
HRPT2 gene must lie within this 14.7-cM nonrecom-
binant region. Although our initial shared haplotype
data provided misleading results, the examination of
shared haplotype data in different families has proven
valuable in refining the map location for other disease
gene loci (i.e., the loci for autosomal dominant Star-
gardt-like macular dystrophy [Donoso et al. 2001] and
primary erythermalgia [Drenth et al. 2001]) and should
continue to be explored in uncommon genetic diseases.
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